Category: Cardiac Rhythm ManagementSyndicate content

Medtronic wins FDA approval for more Attain Performa quad defib leads

December 11, 2014 by Brad Perriello

Medtronic says it won pre-market approval from the FDA for another pair of Attain Performa quadripolar cardiac resynchronization therapy defibrillator leads.

http://phoenix.corporate-ir.net/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=1996836

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical wins CE Mark for Quadra Allure MP pacemaker

December 11, 2014 by Brad Perriello

St. Jude Medical says it won CE Mark approval in the European Union for its Quadra Allure MP pacemaker, claiming it as the sole cardiac resynchronization therapy pacemaker to offer multi-point pacing.

St. Jude Medical wins CE Mark for Quadra Allure MP pacemaker

More positive data for St. Jude Medical's Optim defib leads

December 5, 2014 by Brad Perriello

A long-term study of data from registries set up by St. Jude Medical for its Optim-insulated defibrillator leads shows that they're largely free of the externalized conductor problem that plagued their Riata predecessors.

More positive data for St. Jude Medical's Optim defib leads

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Philips defib updates spur ConMed electrode recall

December 5, 2014 by Mark Hollmer

The FDA assigns Class I recall status to several lines of ConMed's defibrillator electrodes because they won't function with a number of updated devices made by Philips.

ConMed recalls defib leads that don't work with newer Philips devices

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific backs Iowa Approach's atrial fibrillation device

November 24, 2014 by Brad Perriello

Iowa Approach says it landed an investment from Boston Scientific for the ablation device it's developing to treat atrial fibrillation.

Boston Scientific backs Iowa Approach's atrial fibrillation device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic touts CRT data

November 17, 2014 by Brad Perriello

Meta-analyses of Medtronic-sponsored studies show the clinical and economic benefits of its cardiac resynchronization therapy devices.

Medtronic touts CRT data

Medtronic (NYSE:MDT) yesterday touted the results of meta-analyses of a group of company-sponsored studies of its cardiac resynchronization therapy devices, saying the data show the clinical and economic value its CRT portfolio.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic: Hemodialysis patients at risk for arrhythmia

November 14, 2014 by Val Kennedy

A Medtronic study shows hemodialysis patients experience significantly higher-than-expected rates of arrhythmia and that the episodes appeared to coincide with their treatment cycles.

Medtronic: Hemodialysis patients at risk for arrhythmia

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp